I7P-MC-DSAF: Moderate to Severe Hidradenitis Suppurativa

CONDITION

Skin

GENDER

All

AGE GROUP

From 18

to 75 years

STATUS

Active, not recruiting

A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Studies Contact Form

Approved By: Bellberry limited              

Clinical Trial Registry Link:


Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260